Dr. MiltieAtlas by Dr. Miltie™Healthcare Grant Intelligence
Closed — quote deadline passed September 18, 2026 at 4:00 PM Eastern Time
75D301-26-Q-79261

CDC NIOSH Systematic Information Review and Literature Validation Support Services — 75D301-26-Q-79261

FundingContract value is not publicly stated; CDC contemplates one fully funded 36-month firm-fixed-price, deliverable-based commercial-services contract.
DeadlineSeptember 18, 2026 at 4:00 PM Eastern Time under Amendment 00001.
Last verifiedSeptember 18, 2026
Required next actionQuote deadline passed. Keep this canonical record unpublished and monitor SAM.gov for award activity, amendment-based reopening, cancellation, or a successor CDC/NIOSH systematic-information-review procurement. Do not submit a late quote or initiate new outreach.

Broad Eligibility

100% small-business set-aside under NAICS 541990. Offerors must provide an existing commercially available end-to-end systematic-review service and satisfy the RFQ's technical, validation, accessibility, security, and quote-submission requirements.

Atlas Analysis

CDC/NIOSH sought an existing commercially available end-to-end systematic review and evidence-synthesis service under a 100% small-business set-aside, with one fully funded 36-month firm-fixed-price deliverable-based commercial-services contract contemplated. Amendment 00001 and Q&A moved the quote deadline to September 18, 2026 at 4:00 PM Eastern Time. That response window has passed; preserve the record for award/reopening monitoring only.

The Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, is soliciting Systematic Information Review and Literature Validation Support Services under RFQ 75D301-26-Q-79261. The current amended response deadline is September 18, 2026 at 12:00 PM Eastern Time. The acquisition is a 100% small-business set-aside under NAICS 541990 and contemplates one firm-fixed-price, deliverable-based commercial-services contract with a fully funded 36-month period of performance.

CDC is seeking an existing, currently available commercial end-to-end service for systematic literature review and evidence-synthesis workflows. The requirement is for application, configuration, validation, and refinement of an existing service, not development of a new standalone platform or Government-owned system. Required capabilities include title and abstract screening, full-text review, structured extraction into editable outputs with traceability to source text and page references, table parsing or OCR, synthesis and meta-analysis with human review, reproducible audit trails, and validation evidence demonstrating greater than 85% sensitivity and specificity against human reviewers. Section 508 and ICT accessibility documentation, including an applicable ACR or VPAT, is also required.

Qualified small-business vendors should review the latest SAM.gov action and the full RFQ before quoting because the original solicitation attachment still reflects the superseded September 14 deadline. The quote is organized into a Technical Proposal, limited to 20 pages, and a separate Business and Price Proposal. Vendors should confirm that the commercial service, validation evidence, accessibility documentation, security materials, staffing, and pricing package are complete before submission.

Source verificationOfficial government source · sam.govAtlas last verified this record September 18, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗